Image Source: Zacks Investment Research Spikevax, targeting the variant JN.1., is currently approved in the United States, the United Kingdom, Japan and Taiwan. Last month, the FDA approved ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted Moderna COVID-19 vaccine (Spikevax) that targets the JN.1 COVID-19 subvariant. This vaccine is licensed for ...

For the first time in the UK, the updated vaccine, Spikevax® JN.1, will also be available to purchase privately for those who are not eligible for the NHS Autumn vaccination program. The updated ...

In the month, the US regulatory agency approved and granted EUAs to two updated mRNA vaccines, namely Moderna’s Spikevax and Pfizer / BioNTech’s Comirnaty. Both mRNA vaccines were approved for ...

has approved an updated formulation of the COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1., for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals ...

The emergency use authorisation from the FDA allows for Novavax’s updated Covid-19 vaccine to be used in individuals 12 years and older. Credit: Aha-Soft / Shutterstock. Novavax has joined its peers ...

It is going to look a little bizarre, but there is a great reason behind the change… Nike have changed their logo on third kits to celebrate women's football. They explained their switch for ...

Please report side effects. See the full CMI for further details. 1. Why am I being given SPIKEVAX BIVALENT ORIGINAL/ OMICRON BA.4-5? SPIKEVAX BIVALENT ORIGINAL/ OMICRON BA.4-5 contains the active ...

A second study today in the same journal shows the bivalent boosters are particularly effective at preventing hospitalizations in elderly Americans. In the first study, researchers calculated vaccine ...

Novavax's traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA - Moderna's Spikevax and Comirnaty, which is jointly developed by Pfizer ...